Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 48 No. 3 Articles - 2018 Tags: adherence, antipsychotic, Heather Rozea, hospitalization, Jamie C. Barner, Lisa M. Mican, long-acting-injectable, readmission, Thomas J. Maestri

Description

Description

Original Research

Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
By Thomas J. Maestri, Lisa M. Mican, Heather Rozea, Jamie C. Barner

08-15_PB-48-3-2018-Maestri

Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?

Description

Original Research

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

A Pilot Study to Explore the Effect of Long Acting Injectable Antipsychotics on Aggression

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?

Description

Original Research

Related products

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

A Pilot Study to Explore the Effect of Long Acting Injectable Antipsychotics on Aggression

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Agomelatine for Depression in Schizophrenia by Jochen Mutschler